{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:35:59Z","timestamp":1790501759761,"version":"4.1.0"},"reference-count":19,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000292","name":"UK Cystic Fibrosis Trust","doi-asserted-by":"crossref","award":["SDF002"],"award-info":[{"award-number":["SDF002"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2020,8,10]]},"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Relieving gastrointestinal (GI) symptoms was identified as a \u2018top ten\u2019 priority by our James Lind Alliance Priority Setting Partnership in cystic fibrosis (CF). We conducted an online survey to find out more about the effect of GI symptoms in CF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We co-produced an online survey distributed to the CF community via web-based platforms. The survey consisted of open and closed questions designed to help us learn more about the effects of GI symptoms for people with CF (pwCF). We analysed the data using descriptive statistics and thematic analysis. We promoted the survey via social media and web-based platforms which allowed respondents from any country to take part. Our participants came from the CF community, including: adults and children with CF, parents and close family of pwCF and healthcare professionals (HCPs) working with pwCF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There were 276 respondents: 90 (33%) pwCF, 79 (29%) family, 107 (39%) HCPs. The most commonly reported symptoms by lay respondents were stomach cramps\/pain, bloating and a \u2018combination of symptoms\u2019. The top three symptoms that HCPs said were reported to them were reduced appetite, bloating and constipation. Almost all (94% (85\/90)) HCPs thought medications helped to relieve GI symptoms but only 58% (82\/141) of lay respondents agreed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our survey has shown that GI symptoms among our participants are prevalent and intrude on daily lives of pwCF. There is a need for well-designed clinical studies to provide better evidence for management of GI symptoms and complications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2020-000614","type":"journal-article","created":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T03:15:22Z","timestamp":1599534922000},"page":"e000614","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative survey"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4143-5364","authenticated-orcid":false,"given":"Sherie","family":"Smith","sequence":"first","affiliation":[{"name":"Child Health Obstetrics and Gynaecology, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Rowbotham","sequence":"additional","affiliation":[{"name":"Child Health Obstetrics and Gynaecology, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwyneth","family":"Davies","sequence":"additional","affiliation":[{"name":"Institute of Child Health, UCL, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Gathercole","sequence":"additional","affiliation":[{"name":"Person with CF, University of Leeds, Leeds, West Yorkshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J","family":"Collins","sequence":"additional","affiliation":[{"name":"CF Department, Royal Brompton and Harefield NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Elliott","sequence":"additional","affiliation":[{"name":"Mother of Children with CF, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Herbert","sequence":"additional","affiliation":[{"name":"Child Health Obstetrics and Gynaecology, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Allen","sequence":"additional","affiliation":[{"name":"Cystic Fibrosis Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christabella","family":"Ng","sequence":"additional","affiliation":[{"name":"Child Health Obstetrics and Gynaecology, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Smyth","sequence":"additional","affiliation":[{"name":"Child Health Obstetrics and Gynaecology, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"key":"2025083110243270000_7.1.e000614.1","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/s41431-018-0234-z","article-title":"Estimating the age of p.(Phe508del) with family studies of geographically distinct European populations and the early spread of cystic fibrosis","volume":"26","author":"Farrell","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"2025083110243270000_7.1.e000614.2","unstructured":"Cystic Fibrosis Trust . UK cystic fibrosis registry annual data report 2018. London, 2019."},{"key":"2025083110243270000_7.1.e000614.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199310283291804"},{"key":"2025083110243270000_7.1.e000614.4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/2050640619841545","article-title":"A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other Gi disorders","volume":"7","author":"Hayee","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"2025083110243270000_7.1.e000614.5","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.115816"},{"key":"2025083110243270000_7.1.e000614.6","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-210473"},{"key":"2025083110243270000_7.1.e000614.7","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/S1569-1993(19)30575-2","article-title":"P282 gastrointestinal symptoms in people with cystic fibrosis: a survey of lay and professional views","volume":"18","author":"Smith","year":"2019","journal-title":"J Cyst Fibros"},{"key":"2025083110243270000_7.1.e000614.8","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"},{"key":"2025083110243270000_7.1.e000614.9","unstructured":"Cystic Fibrosis Foundation . 2017 patient registry annual data report. Bethesda, Maryland, 2018."},{"key":"2025083110243270000_7.1.e000614.10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174463","article-title":"Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings","volume":"12","author":"Tabori","year":"2017","journal-title":"PLoS One"},{"key":"2025083110243270000_7.1.e000614.11","unstructured":"UK Cystic Fibrosis Trust Nutrition Working Group . Nutritional management of cystic fibrosis. London: Cystic Fibrosis Trust, 2016."},{"key":"2025083110243270000_7.1.e000614.12","unstructured":"NICE . Cystic fibrosis: diagnosis and management. London, 2017."},{"key":"2025083110243270000_7.1.e000614.13","first-page":"CD012949","article-title":"Probiotics for people with cystic fibrosis","volume":"1","author":"Coffey","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2025083110243270000_7.1.e000614.14","article-title":"Postprandial changes in gastrointestinal function and transit in cystic fibrosis assessed by magnetic resonance imaging","author":"Ng","year":"2020","journal-title":"J Cyst Fibros"},{"key":"2025083110243270000_7.1.e000614.15","first-page":"CD010966","article-title":"Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis","volume":"8","author":"Southern","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025083110243270000_7.1.e000614.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105185"},{"key":"2025083110243270000_7.1.e000614.17","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2017.10","article-title":"Impact of CFTR modulation on intestinal pH, motility, and clinical outcomes in patients with cystic fibrosis and the G551D mutation","volume":"8","author":"Gelfond","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"2025083110243270000_7.1.e000614.18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36364-6","article-title":"Impact of CFTR modulation with ivacaftor on gut microbiota and intestinal inflammation","volume":"8","author":"Ooi","year":"2018","journal-title":"Sci Rep"},{"key":"2025083110243270000_7.1.e000614.19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1470-2045(18)30188-8","article-title":"Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis","volume":"19","author":"Yamada","year":"2018","journal-title":"Lancet Oncol"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2020-000614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:24:38Z","timestamp":1756661078000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2020-000614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,9,7]]},"published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1136\/bmjresp-2020-000614"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2020-000614","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}